Stacey Drabic

Person

Gaithersburg, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number RE49908
- Issue date Apr 9, 2024
- MedImmune, LLC
- Srinath Kasturirangan
Information Patent Grant
Methods of administering a composition comprising a Tn3 scaffold an...
- Patent number 11,555,062
- Issue date Jan 17, 2023
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for IL-21 and uses thereof
- Patent number 11,529,415
- Issue date Dec 20, 2022
- Boston Pharmaceuticals Inc.
- Catherine Ettinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 11,279,759
- Issue date Mar 22, 2022
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific m...
- Patent number 11,104,720
- Issue date Aug 31, 2021
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD40L-Fc fusion polypeptides and methods of use thereof
- Patent number 10,975,155
- Issue date Apr 13, 2021
- MedImmune, LLC
- Manuel Baca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies specific for IL-21 and uses thereof
- Patent number 10,588,969
- Issue date Mar 17, 2020
- Boston Pharmaceuticals, Inc.
- Catherine Ettinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 10,457,732
- Issue date Oct 29, 2019
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for IL-21 and uses thereof
- Patent number 10,022,443
- Issue date Jul 17, 2018
- Boston Pharmaceuticals Inc.
- Catherine Ettinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD40L-specific TN3-derived scaffolds and methods of use thereof
- Patent number 10,000,553
- Issue date Jun 19, 2018
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF
- Publication number 20230201346
- Publication date Jun 29, 2023
- Boston Pharmaceuticals Inc.
- Catherine Ettinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20220251204
- Publication date Aug 11, 2022
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEIC ACIDS ENCODING A TN3 SCAFFOLD COMPRISING A CD40L-SPECIFIC M...
- Publication number 20220089688
- Publication date Mar 24, 2022
- Viela Bio, Inc.
- Anthony COYLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210260159
- Publication date Aug 26, 2021
- Medimmune, LLC
- Manuel Baca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF
- Publication number 20200164069
- Publication date May 28, 2020
- Boston Pharmaceuticals Inc.
- Catherine Ettinger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF
- Publication number 20180318416
- Publication date Nov 8, 2018
- Boston Pharmaceuticals Inc.
- Catherine Ettinger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD40L-Specific TN3-Derived Scaffolds and Methods Of Use Thereof
- Publication number 20180312572
- Publication date Nov 1, 2018
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20180022807
- Publication date Jan 25, 2018
- Medimmune, LLC
- Srinath KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD40L-Fc Fusion Polypeptides And Methods Of Use Thereof
- Publication number 20170327588
- Publication date Nov 16, 2017
- Medimmune, LLC
- Manuel Baca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF
- Publication number 20170173149
- Publication date Jun 22, 2017
- Boston Pharmaceuticals Inc.
- Catherine Ettinger
- G01 - MEASURING TESTING
Information Patent Application
CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS AND METHODS OF USE THEREOF
- Publication number 20150098955
- Publication date Apr 9, 2015
- Medlmmune, LLC
- Anthony Coyle
- C07 - ORGANIC CHEMISTRY

Stacey Drabic

Person

Patents Grantslast 30 patents

Bispecific binding proteins and uses thereof

Methods of administering a composition comprising a Tn3 scaffold an...

Antibodies specific for IL-21 and uses thereof

Bispecific binding proteins and uses thereof

Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific m...

CD40L-Fc fusion polypeptides and methods of use thereof

Antibodies specific for IL-21 and uses thereof

Bispecific binding proteins and uses thereof

Antibodies specific for IL-21 and uses thereof

CD40L-specific TN3-derived scaffolds and methods of use thereof

Patents Applicationslast 30 patents

BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF

BISPECIFIC BINDING PROTEINS AND USES THEREOF

NUCLEIC ACIDS ENCODING A TN3 SCAFFOLD COMPRISING A CD40L-SPECIFIC M...

CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF

BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF

CD40L-Specific TN3-Derived Scaffolds and Methods Of Use Thereof

BISPECIFIC BINDING PROTEINS AND USES THEREOF

CD40L-Fc Fusion Polypeptides And Methods Of Use Thereof

BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF

CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS AND METHODS OF USE THEREOF